drugset / Trial / NCT06996236
Brimonidine Eye Drops in the Prevention of Myopia Progression
Phase 2
Not yet recruiting
40 enrolled
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
NaSingle-groupOpen-labelPrevention
Summary
Study to determine the efficacy of alpha-2 adrenergic drugs (brimonidine) in the prevention of myopia progression. Given that the drugs used so far have limited efficacy and side effects (loss of near vision, photophobia), it may be an interesting contribution to such treatment at low cost, and to avoid the expense of managing the complications of myopia that develop throughout life.
Timeline
- Start
- 2025-07
- Primary completion
- 2026-07
- Completion
- 2027-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Brimonidine | Small molecule | 0.025 % | Topical |